City Holding Co. Has $728,000 Position in MetLife, Inc. (NYSE:MET)

City Holding Co. grew its position in MetLife, Inc. (NYSE:METFree Report) by 39.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 8,825 shares of the financial services provider’s stock after purchasing an additional 2,500 shares during the period. City Holding Co.’s holdings in MetLife were worth $728,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in MET. Atomi Financial Group Inc. boosted its position in MetLife by 44.4% in the third quarter. Atomi Financial Group Inc. now owns 6,090 shares of the financial services provider’s stock valued at $502,000 after buying an additional 1,873 shares in the last quarter. Chesley Taft & Associates LLC raised its stake in shares of MetLife by 3.3% in the third quarter. Chesley Taft & Associates LLC now owns 17,630 shares of the financial services provider’s stock valued at $1,454,000 after acquiring an additional 563 shares during the last quarter. Alpha Cubed Investments LLC boosted its holdings in shares of MetLife by 3.8% in the 3rd quarter. Alpha Cubed Investments LLC now owns 295,829 shares of the financial services provider’s stock worth $24,400,000 after acquiring an additional 10,729 shares in the last quarter. Aprio Wealth Management LLC bought a new stake in MetLife during the 3rd quarter worth approximately $291,000. Finally, Mather Group LLC. increased its holdings in MetLife by 31.6% during the 3rd quarter. Mather Group LLC. now owns 7,417 shares of the financial services provider’s stock valued at $612,000 after purchasing an additional 1,782 shares in the last quarter. Institutional investors own 89.81% of the company’s stock.

MetLife Trading Up 1.5 %

NYSE MET opened at $84.54 on Thursday. MetLife, Inc. has a one year low of $57.91 and a one year high of $85.07. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a market cap of $60.12 billion, a P/E ratio of 29.05, a P/E/G ratio of 0.66 and a beta of 1.04. The stock’s 50-day moving average is $76.25 and its 200-day moving average is $73.47.

MetLife (NYSE:METGet Free Report) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $2.28 EPS for the quarter, topping the consensus estimate of $2.13 by $0.15. MetLife had a net margin of 4.23% and a return on equity of 21.41%. The firm had revenue of $17.82 billion for the quarter, compared to the consensus estimate of $18.57 billion. During the same period last year, the company posted $1.94 EPS. The business’s quarterly revenue was up 7.2% on a year-over-year basis. Sell-side analysts anticipate that MetLife, Inc. will post 8.68 earnings per share for the current fiscal year.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.58%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio is 74.91%.

Analyst Ratings Changes

Several analysts have recently commented on the company. Piper Sandler increased their target price on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a report on Friday, October 4th. TD Cowen initiated coverage on shares of MetLife in a research report on Wednesday. They set a “buy” rating and a $97.00 target price on the stock. Morgan Stanley lowered their price target on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research report on Monday, August 19th. Finally, Jefferies Financial Group increased their price objective on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 27th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $88.00.

View Our Latest Stock Analysis on MET

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.